ReCor Medical, Inc. — Biomedical Watch V2

Traitements5programmes

Essais2liés

Publications9liées

SourceDBlocale

Traitements

5

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Paradise Ultrasound Renal Denervation TreatmentThe objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a catheter, cable, balloon, and generator and has received FDA approval in the United States. Information collected in this study will be analyzed to better understand the long-term safety and effectiveness of treatment with the Paradise System for patients with high blood pressure.	Hypertension	À vérifier	À vérifier	United States	À vérifier
Sham ProcedureThe objective of the study is to investigate the safety and effectiveness of PFO closure with the BioSTAR Septal Repair Implant System in a population of patients that have refractory migraine (with aura) and who have failed medications.	Hypertension, Migraine	Non applicable	À vérifier	United States, Belgium, France, Germany, Netherlands, Poland, United Kingdom	À vérifier
The Paradise® Renal Denervation Ultrasound SystemRADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.	Hypertension	Non applicable	À vérifier	United States, Belgium, France, Germany, Netherlands, Poland, United Kingdom	À vérifier
The Paradise® Renal Denervation Ultrasound SystemRADIANCE-HTN is a randomized, double-blind, sham controlled, 2-cohort study (TRIO and SOLO) designed to demonstrate efficacy and document the safety of the Paradise Renal Denervation System in two distinct populations of hypertensive subjects.	Hypertension	Non applicable	À vérifier	United States, Belgium, France, Germany, Netherlands, Poland, United Kingdom	À vérifier
Paradise Ultrasound Renal Denervation TreatmentThe objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a catheter, cable, balloon, and generator and has received FDA approval in the United States. Information collected in this study will be analyzed to better understand the long-term safety and effectiveness of treatment with the Paradise System for patients with high blood pressure.	Hypertension	À vérifier	À vérifier	United States	À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
Paradise Ultrasound Renal Denervation Treatment	Hypertension	À vérifier	NCT06297291	US GPS — Global Paradise System US Post Approval Study	RECRUITING
The Paradise® Renal Denervation Ultrasound System	Hypertension	Non applicable	NCT02649426	RADIANCE-HTN — A Study of the ReCor Medical Paradise System in Clinical Hypertension	ACTIVE_NOT_RECRUITING

Publications

9

Molécule	Indication / population	Titre	Journal	Date
The Paradise® Renal Denervation Ultrasound System		Effects of renal denervation on the incidence and severity of cardiovascular diseases.	Hypertension research : official journal of the Japanese Society of Hypertension
The Paradise® Renal Denervation Ultrasound System		Renal nerves in physiology, pathophysiology and interoception.	Nature reviews. Nephrology
Sham Procedure		Long-term outcomes of genicular artery embolization for knee osteoarthritis: 12-month efficacy and secondary outcomes from a randomized sham-controlled clinical trial.	European radiology
Sham Procedure		Effect of Adding Erector Spinae Plane Block to a Multimodal Analgesic Regimen on Quality of Recovery After Laparoscopic Colon Cancer Surgery: A Prospective Randomized Controlled Trial.	Journal of pain research
Paradise Ultrasound Renal Denervation Treatment		Renal Denervation to Treat Hypertension: A Clinical State-of-the-Art Review.	American journal of hypertension
The Paradise® Renal Denervation Ultrasound System		Cost-Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The Netherlands.	PharmacoEconomics - open
The Paradise® Renal Denervation Ultrasound System		Renal denervation increases capillary density in hypertensive patients.	European journal of preventive cardiology
Sham Procedure		Novel neonatal hypoxic-ischemic model demonstrates glial activation and memory deficits without neuronal loss.	Pediatric research
Sham Procedure		Dual Stellate Ganglion Blocks for Managing Treatment-Resistant Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.	Pain physician